Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2011 1
2014 2
2015 2
2017 1
2019 2
2020 2
2021 2
2022 2
2023 2
2024 1
2025 3
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma.
Lasa M, Notarfranchi L, Agullo C, Gonzalez C, Castro S, Perez JJ, Burgos L, Guerrero C, Calasanz MJ, Flores-Montero J, Oriol A, Bargay J, Rios R, Cabañas V, Cabrera C, Martinez-Martinez R, Encinas C, De Arriba F, Hernandez MT, Palomera L, Orfao A, Martinez-Lopez J, Mateos MV, San-Miguel J, Lahuerta JJ, Rosiñol L, Blade J, Cedena MT, Puig N, Paiva B; PETHEMA/GEM Cooperative Group. Lasa M, et al. J Clin Oncol. 2025 Jan 10;43(2):125-132. doi: 10.1200/JCO.24.00635. Epub 2024 Oct 1. J Clin Oncol. 2025. PMID: 39353166
ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significance.
Sánchez-Maldonado JM, Macauda A, Cabrera-Serrano AJ, Thomsen H, Güler M, Horst RT, van Guelpen B, Vodicka P, Landi S, Chattopadhyay S, Ünal P, Ruiz-Durán L, Casabonne D, Goldschmidt H, Serin I, Carretero-Fernández M, Cabezudo E, Reyes-Zurita F, Norman AD, García-Sanz R, Capurso G, Hoffmann P, Pettersson-Kymmer U, Jiménez-Romera F, Rajkumar SV, Weinhold N, Vodickova L, Langer C, Stein A, Karismaz A, Moreno V, Nöthen MM, Jöckel KH, Tavano F, Martínez-López J, Kumar SK, Gutiérrez-Bautista JF, Basso D, Späth F, Benavente Y, Hildebrandt MAT, Schmidt B, Sevcikova T, Reis RMV, Li Y, López-Nevot MÁ, Netea MG, Campa D, Clay-Gilmour A, Slager SL, Hemminki K, Vachon CM, Försti A, Canzian F, Sainz J. Sánchez-Maldonado JM, et al. Among authors: cabezudo e. Int J Cancer. 2026 Mar 11. doi: 10.1002/ijc.70427. Online ahead of print. Int J Cancer. 2026. PMID: 41813586
Lenalidomide and dexamethasone maintenance with or without ixazomib, tailored by residual disease status in myeloma.
Rosiñol L, Oriol A, Ríos R, Blanchard MJ, Jarque I, Bargay J, Hernández MT, Cabañas V, Carrillo-Cruz E, Sureda A, Martínez-López J, Krsnik I, González ME, Casado LF, Martí JM, Encinas C, de Arriba F, Palomera L, Sampol A, González-Montes Y, Cabezudo E, Paiva B, Puig N, Cedena MT, de la Cruz J, Mateos MV, San Miguel J, Lahuerta JJ, Bladé J. Rosiñol L, et al. Among authors: cabezudo e. Blood. 2023 Nov 2;142(18):1518-1528. doi: 10.1182/blood.2022019531. Blood. 2023. PMID: 37506339 Free article. Clinical Trial.
Real-World Evidence of Daratumumab Monotherapy in Relapsed/Refractory Multiple Myeloma Patients and Efficacy on Soft-Tissue Plasmacytomas.
Moreno DF, Clapés V, Soler JA, González-Montes Y, Gironella M, Motlló C, Granell M, Abella E, García-Pintos M, García-Guiñón A, Cabezudo E, Bladé J, Rosiñol L. Moreno DF, et al. Among authors: cabezudo e. Clin Lymphoma Myeloma Leuk. 2022 Aug;22(8):635-642. doi: 10.1016/j.clml.2022.04.014. Epub 2022 Apr 17. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35610120
What matters most to patients with multiple myeloma? A Pan-European patient preference study.
Janssens R, Lang T, Vallejo A, Galinsky J, Morgan K, Plate A, De Ronne C, Verschueren M, Schoefs E, Vanhellemont A, Delforge M, Schjesvold F, Cabezudo E, Vandebroek M, Stevens H, Simoens S, Huys I. Janssens R, et al. Among authors: cabezudo e. Front Oncol. 2022 Nov 29;12:1027353. doi: 10.3389/fonc.2022.1027353. eCollection 2022. Front Oncol. 2022. PMID: 36523996 Free PMC article.
Postpartum ovarian vein thrombosis.
Ortín X, Ugarriza A, Espax RM, Boixadera J, Llorente A, Escoda L, Cabezudo E. Ortín X, et al. Among authors: cabezudo e. Thromb Haemost. 2005 May;93(5):1004-5. Thromb Haemost. 2005. PMID: 15900650 No abstract available.
Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative Study.
Janssens R, Lang T, Vallejo A, Galinsky J, Plate A, Morgan K, Cabezudo E, Silvennoinen R, Coriu D, Badelita S, Irimia R, Anttonen M, Manninen RL, Schoefs E, Vandebroek M, Vanhellemont A, Delforge M, Stevens H, Simoens S, Huys I. Janssens R, et al. Among authors: cabezudo e. Front Med (Lausanne). 2021 Jul 6;8:686165. doi: 10.3389/fmed.2021.686165. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34295912 Free PMC article.
18 results